You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +43 (0)1 71 72 8 900 or email: apus@templetonapus.com |
|
Most viewed
- 1. How AI is helping to make breast cancer history
- 2. Immuno-oncology biotech IO Biotech files for a $100 million IPO
- 3. The FirstTake Podcast - CAR-T, early-stage breast cancer and OX40
- 4. Cancer and the risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort study including 4,618,377 adults in Catalonia, Spain
- 5. Therapeutically leveraging GABAA receptors in cancer
- 6. Supportive care in multiple myeloma: Current practices and advances
- 7. A comprehensive review of the impact of obesity on plasma cell disorders
- 8. Cardiovascular complications associated with novel agents in the chronic lymphocytic leukemia armamentarium: A pharmacovigilance analysis
- 9. Paving the Way for a More Targeted Treatment of Cancer
- 10. Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
Last updated at 20:23 GMT
Hot News Makers
Health/Pharma Companies
-
288447.42
-
48859.91
-
43265.31
-
31606.88
-
26477.34
-
20633.16
-
19567.30
-
16933.50
-
14257.55
-
13943.00
Last updated at 20:10 GMT